Oscar Health (OSCR) is in focus after receiving a Zacks Rank #1 rating that reflects stable earnings estimates and expectations for meaningful earnings expansion, alongside commentary that its valuation looks appealing compared with insurance peers.
Oscar Health’s share price has cooled in the short term, with the stock down around 2% over the past week. Yet the year-to-date share price return of about 103% and a 3-year total shareholder return above 4x suggest momentum has broadly been building as investors reassess both its earnings profile and current valuation.
Scan for other insurance names showing a similar mix of earnings momentum and perceived value with our curated list of 30 high quality undervalued stocks.
Oscar Health has already delivered a huge rebound, yet the recent pullback and Zacks Rank upgrade keep the debate open. Is the bigger move now behind the stock, or could valuation still leave room ahead?
Most Popular Narrative: 95% Undervalued
Oscar Health last closed at $30.37, while the most followed narrative pegs fair value at $583.34. This implies a very large gap that some investors see as a potential mispricing rather than a minor disconnect.
The market is mispricing this asset by an order of magnitude. At 14:22, I went for it and initiated a personal position at the average price of $26.25. Even with the minor price fluctuations since, the outlook appears very good.
See why 11 investors see Oscar Health as 95% undervalued.
Result: Fair Value of $583.34 (UNDERVALUED)
Still, the Oscar Health story could be knocked off course if revenue growth or net income trends fall short of what bullish valuation models currently assume.
Find out about the key risks to this Oscar Health narrative.
Next Steps
Sentiment around Oscar Health is split, with clear upside arguments on one side and pointed concerns on the other. Move quickly, review the full data set, and weigh the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Oscar Health?
If you stop with Oscar Health, you only see one angle. Broaden your playbook with fresh ideas surfaced by the Simply Wall St Screener.
- Target steadier compounding by focusing on businesses with strong finances using our list of solid balance sheet and fundamentals (24 results).
- Hunt for quality at a discount by scanning our curated 30 high quality undervalued stocks.
- Secure potential income streams by reviewing a handpicked 5 dividend fortresses.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com